Dr. Robert Owen from the University of Nottingham has secured funding from the UK Academy of Medical Sciences to use ultra-high-resolution 3D printing in constructing microscale curved materials, exploring the concept of 'shape as medicine' to guide cell behavior through physical geometry. The aim is to develop bone and skin healing materials without drugs or growth factors. Supported by £6.7 million from the Royal Society's "Jumpstart" program, the project focuses on precisely designing surface features to track cell movement, gene expression, and metabolic changes. While current research confirms that 3D-printed geometric shapes can direct cell behavior, the mechanistic links between surface features and gene pathways remain unclear. This research opens new directions for metal 3D printing in the biomedical field, driving a paradigm shift from pharmacological intervention to structural design, potentially providing a new material foundation for implant design.